Your Source for Venture Capital and Private Equity Financings

eGenesis Inks $38M in Series A Financing

2017-03-25
CAMBRIDGE, MA, eGenesis raises $38M in Series A Financing led by Biomatics Capital and ARCH Venture Partners.
eGenesis has raised $38M in Series A financing. The funding was led by Biomatics Capital and ARCH Venture Partners. Also participating were Khosla Ventures, Alta Partners, Alexandria Equities, Heritage Provider Network, Berggruen Holdings North America, Uprising, and Fan Ventures.

eGenesis is a life sciences company focused on leveraging CRISPR technology to deliver safe and effective human transplantable cells, tissues and organs to the hundreds of thousands of patients worldwide who are in dire need.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors